07:00 , May 23, 2011 |  BC Week In Review  |  Company News

Commercial E Waste Management, FluoroPharma deal

FluoroPharma completed its reverse merger with Commercial E Waste Management to form FluoroPharma Medical Inc. (OTCBB:CEWM). Under the deal, FluoroPharma Inc. shareholders received about 13.9 million FluoroPharma Medical shares and 661,617 warrants to purchase shares...
07:00 , Jul 28, 2008 |  BC Week In Review  |  Clinical News

BFPET: Phase I data

In an open-label, U.S. Phase I trial in 12 healthy volunteers, single injections of BFPET were well tolerated and had rapid blood clearance and myocardial uptake. FluoroPharma Inc. , Boston, Mass.   Product: BFPET  ...
07:00 , Mar 24, 2008 |  BC Week In Review  |  Clinical News

BFPET: Phase I started

FluoroPharma began an open-label, U.S. Phase I trial to evaluate a single IV dose of BFPET in 12 healthy volunteers. FluoroPharma Inc. , Boston, Mass.   Product: BFPET   Business: Diagnostic   Molecular target: NA...